Positive Association of US-FLI With the Severity of CAD
Positive Association Between Ultrasonographic Fatty Liver Indicator and the Severity of Coronary Artery Disease
Chongqing Medical University
190 participants
Jul 1, 2022
OBSERVATIONAL
Conditions
Summary
As a multisystem disease, metabolic dysfunction-associated fatty liver disease (MAFLD) is closely linked to the onset and progression of coronary heart disease (CHD). Ultrasonographic fatty liver indicator (US-FLI) is a semi-quantitative tool for evaluating the degree of hepatic steatosis. Our study aims to explore the relationship between US-FLI based on MAFLD and the severity of CHD.
Eligibility
Inclusion Criteria2
- Patients older than 18 years old
- Patients underwent ICA due to chest pain, chest tightness or other reasons in our hospital from August 2022 to December 2023 were included in our study
Exclusion Criteria7
- Incomplete clinical data
- previous coronary stent implantation
- no abdominal ultrasound examination
- poor ultrasound image quality
- congenital heart disease
- tumor
- thyroid diseases and infectious diseases
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Observational study without human intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06541132